GE HealthCare expands photon-counting CT research network

GE HealthCare logo featuring purple circular symbol with white GE monogram and company name

GE HealthCare is broadening its clinical and research collaborations for Photonova Spectra, its photon-counting CT system based on Deep Silicon detector technology. 

The move follows the system’s CE Mark, its U.S. Food and Drug Administration (FDA) 510(k) clearance, and approval from Japan’s Pharmaceuticals and Medical Devices Agency. The network now includes seven institutions in North America, Europe, and Asia, which will evaluate the system’s image quality, spectral performance, workflow, and diagnostic utility, the company said. New and expanded sites and their areas of focus include the following: 

  • Keio University Hospital (Tokyo): Quantitative and spectral imaging techniques and emerging clinical applications. 

  • Centro Cardiologico Monzino IRCCS (Milan): Cardiovascular imaging, including quantitative assessment and tissue characterization. 

  • University Hospital Zurich (Switzerland): Coronary CT angiography (CCTA), with researchers in its nuclear medicine department working on how to lower radiation dose without losing diagnostic performance. 

  • University of Wisconsin-Madison (Madison, WI): A renewed collaboration on imaging protocols, quantitative performance, and technical measures of image quality. 

  • Stanford Medicine (Palo Alto, CA): Expanded technical and human-subject studies of reconstruction methods, image presentation workflows, and disease-specific applications, including tissue characterization and potential imaging biomarkers. 

UZ Brussel in Belgium and Rigshospitalet in Copenhagen, Denmark, joined the program after the system received its CE Mark. They are studying cardiac imaging and pediatric and low-dose applications, respectively, according to GE HealthCare.

Page 1 of 618
Next Page